- Home
- MLYS vs NDMO Comparison
MLYS vs NDMO Comparison
Compare MLYS & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- NDMO
- Stock Information
- Founded
- MLYS 2019
- NDMO 2019
- Country
- MLYS United States
- NDMO United States
- Employees
- MLYS N/A
- NDMO N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- MLYS Health Care
- NDMO Finance
- Exchange
- MLYS Nasdaq
- NDMO Nasdaq
- Market Cap
- MLYS 1.0B
- NDMO N/A
- IPO Year
- MLYS 2023
- NDMO N/A
- Fundamental
- Price
- MLYS $13.84
- NDMO $10.07
- Analyst Decision
- MLYS Strong Buy
- NDMO
- Analyst Count
- MLYS 4
- NDMO 0
- Target Price
- MLYS $27.00
- NDMO N/A
- AVG Volume (30 Days)
- MLYS 827.2K
- NDMO 218.6K
- Earning Date
- MLYS 08-12-2025
- NDMO 01-01-0001
- Dividend Yield
- MLYS N/A
- NDMO 6.75%
- EPS Growth
- MLYS N/A
- NDMO N/A
- EPS
- MLYS N/A
- NDMO N/A
- Revenue
- MLYS N/A
- NDMO N/A
- Revenue This Year
- MLYS N/A
- NDMO N/A
- Revenue Next Year
- MLYS N/A
- NDMO N/A
- P/E Ratio
- MLYS N/A
- NDMO N/A
- Revenue Growth
- MLYS N/A
- NDMO N/A
- 52 Week Low
- MLYS $8.24
- NDMO $8.99
- 52 Week High
- MLYS $18.38
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- MLYS 42.26
- NDMO 50.17
- Support Level
- MLYS $12.95
- NDMO $9.96
- Resistance Level
- MLYS $14.09
- NDMO $10.04
- Average True Range (ATR)
- MLYS 0.77
- NDMO 0.10
- MACD
- MLYS -0.14
- NDMO -0.02
- Stochastic Oscillator
- MLYS 28.24
- NDMO 22.50
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.